APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anticoagulants

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Anticoagulants Industry Research Report 2026

20 December 2025138 pages

Choose your research edition.

Industry ResearchOral Anticoagulants Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anticoagulants Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Oral Anticoagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anticoagulants Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anticoagulants Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Oral Anticoagulants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Anticoagulants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Anticoagulants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Anticoagulants include Eisai, Sanofi, Johnson & Johnson, GSK, Daiichi Sankyo, Bayer, AstraZeneca, Perosphere and Ockham Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Anticoagulants market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Anticoagulants Market by Company

Eisai

Sanofi

Johnson & Johnson

GSK

Daiichi Sankyo

Bayer

AstraZeneca

Perosphere

Ockham Biotech

Marathon Pharmaceuticals

CSL Behring

Cosmo Pharmaceuticals

Cellceutix

Bristol-Myers Squibb

Boehringer Ingelheim

Aspen

Armatheon

Oral Anticoagulants Segment by Type

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Oral Anticoagulants Segment by Application

Hemodialysis

Deep Vein Thrombosis (DVT)

Acute Coronary Syndrome

Pulmonary Embolism

Others

Oral Anticoagulants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anticoagulants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Anticoagulants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Anticoagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Anticoagulants Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Anticoagulants Sales (k units) of Manufacturers (2021-2026) Table 7. Global Oral Anticoagulants Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Anticoagulants Revenue of Manufacturers (2021-2026) Table 9. Global Oral Anticoagulants Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Anticoagulants Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Oral Anticoagulants Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Anticoagulants, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Anticoagulants, Product Type & Application Table 14. Global Oral Anticoagulants Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Anticoagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Eisai Company Information Table 19. Eisai Business Overview Table 20. Eisai Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Eisai Oral Anticoagulants Product Portfolio Table 22. Eisai Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sanofi Oral Anticoagulants Product Portfolio Table 27. Sanofi Recent Developments Table 28. Johnson & Johnson Company Information Table 29. Johnson & Johnson Business Overview Table 30. Johnson & Johnson Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Johnson & Johnson Oral Anticoagulants Product Portfolio Table 32. Johnson & Johnson Recent Developments Table 33. GSK Company Information Table 34. GSK Business Overview Table 35. GSK Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. GSK Oral Anticoagulants Product Portfolio Table 37. GSK Recent Developments Table 38. Daiichi Sankyo Company Information Table 39. Daiichi Sankyo Business Overview Table 40. Daiichi Sankyo Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Daiichi Sankyo Oral Anticoagulants Product Portfolio Table 42. Daiichi Sankyo Recent Developments Table 43. Bayer Company Information Table 44. Bayer Business Overview Table 45. Bayer Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Bayer Oral Anticoagulants Product Portfolio Table 47. Bayer Recent Developments Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. AstraZeneca Oral Anticoagulants Product Portfolio Table 52. AstraZeneca Recent Developments Table 53. Perosphere Company Information Table 54. Perosphere Business Overview Table 55. Perosphere Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Perosphere Oral Anticoagulants Product Portfolio Table 57. Perosphere Recent Developments Table 58. Ockham Biotech Company Information Table 59. Ockham Biotech Business Overview Table 60. Ockham Biotech Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Ockham Biotech Oral Anticoagulants Product Portfolio Table 62. Ockham Biotech Recent Developments Table 63. Marathon Pharmaceuticals Company Information Table 64. Marathon Pharmaceuticals Business Overview Table 65. Marathon Pharmaceuticals Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio Table 67. Marathon Pharmaceuticals Recent Developments Table 68. CSL Behring Company Information Table 69. CSL Behring Business Overview Table 70. CSL Behring Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. CSL Behring Oral Anticoagulants Product Portfolio Table 72. CSL Behring Recent Developments Table 73. Cosmo Pharmaceuticals Company Information Table 74. Cosmo Pharmaceuticals Business Overview Table 75. Cosmo Pharmaceuticals Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio Table 77. Cosmo Pharmaceuticals Recent Developments Table 78. Cellceutix Company Information Table 79. Cellceutix Business Overview Table 80. Cellceutix Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Cellceutix Oral Anticoagulants Product Portfolio Table 82. Cellceutix Recent Developments Table 83. Bristol-Myers Squibb Company Information Table 84. Bristol-Myers Squibb Business Overview Table 85. Bristol-Myers Squibb Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bristol-Myers Squibb Oral Anticoagulants Product Portfolio Table 87. Bristol-Myers Squibb Recent Developments Table 88. Boehringer Ingelheim Company Information Table 89. Boehringer Ingelheim Business Overview Table 90. Boehringer Ingelheim Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Boehringer Ingelheim Oral Anticoagulants Product Portfolio Table 92. Boehringer Ingelheim Recent Developments Table 93. Aspen Company Information Table 94. Aspen Business Overview Table 95. Aspen Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Aspen Oral Anticoagulants Product Portfolio Table 97. Aspen Recent Developments Table 98. Armatheon Company Information Table 99. Armatheon Business Overview Table 100. Armatheon Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Armatheon Oral Anticoagulants Product Portfolio Table 102. Armatheon Recent Developments Table 103. Global Oral Anticoagulants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Oral Anticoagulants Sales by Region (2021-2026) & (k units) Table 105. Global Oral Anticoagulants Sales Market Share by Region (2021-2026) Table 106. Global Oral Anticoagulants Sales by Region (2027-2032) & (k units) Table 107. Global Oral Anticoagulants Sales Market Share by Region (2027-2032) Table 108. Global Oral Anticoagulants Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Oral Anticoagulants Revenue Market Share by Region (2021-2026) Table 110. Global Oral Anticoagulants Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Oral Anticoagulants Revenue Market Share by Region (2027-2032) Table 112. North America Oral Anticoagulants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 114. North America Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 115. North America Oral Anticoagulants Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Oral Anticoagulants Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Oral Anticoagulants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 119. Europe Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 120. Europe Oral Anticoagulants Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Oral Anticoagulants Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Oral Anticoagulants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Oral Anticoagulants Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Oral Anticoagulants Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Oral Anticoagulants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 129. South America Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 130. South America Oral Anticoagulants Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Oral Anticoagulants Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Oral Anticoagulants Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Oral Anticoagulants Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Oral Anticoagulants Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Oral Anticoagulants Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 138. Global Oral Anticoagulants Sales by Type (2027-2032) & (k units) Table 139. Global Oral Anticoagulants Sales Market Share by Type (2021-2026) Table 140. Global Oral Anticoagulants Sales Market Share by Type (2027-2032) Table 141. Global Oral Anticoagulants Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Oral Anticoagulants Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Oral Anticoagulants Revenue Market Share by Type (2021-2026) Table 144. Global Oral Anticoagulants Revenue Market Share by Type (2027-2032) Table 145. Global Oral Anticoagulants Price by Type (2021-2026) & (US$/unit) Table 146. Global Oral Anticoagulants Price by Type (2027-2032) & (US$/unit) Table 147. Global Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 148. Global Oral Anticoagulants Sales by Application (2027-2032) & (k units) Table 149. Global Oral Anticoagulants Sales Market Share by Application (2021-2026) Table 150. Global Oral Anticoagulants Sales Market Share by Application (2027-2032) Table 151. Global Oral Anticoagulants Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Oral Anticoagulants Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Oral Anticoagulants Revenue Market Share by Application (2021-2026) Table 154. Global Oral Anticoagulants Revenue Market Share by Application (2027-2032) Table 155. Global Oral Anticoagulants Price by Application (2021-2026) & (US$/unit) Table 156. Global Oral Anticoagulants Price by Application (2027-2032) & (US$/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Oral Anticoagulants Distributors List Table 160. Oral Anticoagulants Customers List Table 161. Oral Anticoagulants Industry Trends Table 162. Oral Anticoagulants Industry Drivers Table 163. Oral Anticoagulants Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Anticoagulants Product Image Figure 5. Global Oral Anticoagulants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Anticoagulants Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Anticoagulants Sales (2021-2032) & (k units) Figure 8. Global Oral Anticoagulants Average Price (US$/unit) & (2021-2032) Figure 9. Direct Thrombin Inhibitors Product Image Figure 10. Direct Factor Xa Inhibitors Product Image Figure 11. Hemodialysis Product Image Figure 12. Deep Vein Thrombosis (DVT) Product Image Figure 13. Acute Coronary Syndrome Product Image Figure 14. Pulmonary Embolism Product Image Figure 15. Others Product Image Figure 16. Global Oral Anticoagulants Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Oral Anticoagulants, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Oral Anticoagulants Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Oral Anticoagulants Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Oral Anticoagulants Sales by Region in 2025 Figure 22. Global Oral Anticoagulants Revenue by Region in 2025 Figure 23. North America Oral Anticoagulants Market Size by Country in 2025 Figure 24. North America Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 25. North America Oral Anticoagulants Revenue Market Share by Country (2021-2032) Figure 26. United States Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Oral Anticoagulants Market Size by Country in 2025 Figure 30. Europe Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 31. Europe Oral Anticoagulants Revenue Market Share by Country (2021-2032) Figure 32. Germany Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Oral Anticoagulants Market Size by Country in 2025 Figure 43. Asia Pacific Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Oral Anticoagulants Revenue Market Share by Country (2021-2032) Figure 45. China Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Oral Anticoagulants Market Size by Country in 2025 Figure 54. South America Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 55. South America Oral Anticoagulants Revenue Market Share by Country (2021-2032) Figure 56. Brazil Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Oral Anticoagulants Market Size by Country in 2025 Figure 60. Middle East and Africa Oral Anticoagulants Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Oral Anticoagulants Revenue Market Share by Country (2021-2032) Figure 62. Egypt Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Oral Anticoagulants Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Oral Anticoagulants Sales Market Share by Type (2021-2032) Figure 68. Global Oral Anticoagulants Revenue Market Share by Type (2021-2032) Figure 69. Global Oral Anticoagulants Price (US$/unit) by Type (2021-2032) Figure 70. Global Oral Anticoagulants Sales Market Share by Application (2021-2032) Figure 71. Global Oral Anticoagulants Revenue Market Share by Application (2021-2032) Figure 72. Global Oral Anticoagulants Price (US$/unit) by Application (2021-2032) Figure 73. Oral Anticoagulants Value Chain Figure 74. Oral Anticoagulants Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Oral Anticoagulants Industry Opportunities and Challenges

Scope & coverage.

Types
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors
Applications
  • Hemodialysis
  • Deep Vein Thrombosis (DVT)
  • Acute Coronary Syndrome
  • Pulmonary Embolism
  • Others
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • GSK
  • Daiichi Sankyo
  • Bayer
  • AstraZeneca
  • Perosphere
  • Ockham Biotech
  • Marathon Pharmaceuticals
  • CSL Behring
  • Cosmo Pharmaceuticals
  • Cellceutix
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Aspen
  • Armatheon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Anticoagulants Market Size (2021-2032)
  4. 2.2.2 Global Oral Anticoagulants Sales (2021-2032)
  5. 2.2.3 Global Oral Anticoagulants Market Average Price (2021-2032)
  6. 2.3 Oral Anticoagulants by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Direct Thrombin Inhibitors
  9. 2.3.3 Direct Factor Xa Inhibitors
  10. 2.4 Oral Anticoagulants by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hemodialysis
  13. 2.4.3 Deep Vein Thrombosis (DVT)
  14. 2.4.4 Acute Coronary Syndrome
  15. 2.4.5 Pulmonary Embolism
  16. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Anticoagulants Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Anticoagulants Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Anticoagulants Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Anticoagulants Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Anticoagulants Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Anticoagulants, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Anticoagulants, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Anticoagulants, Established Date
  9. 3.9 Global Oral Anticoagulants Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Eisai
  2. 4.1.1 Eisai Company Information
  3. 4.1.2 Eisai Business Overview
  4. 4.1.3 Eisai Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Eisai Oral Anticoagulants Product Portfolio
  6. 4.1.5 Eisai Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Oral Anticoagulants Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Johnson & Johnson
  14. 4.3.1 Johnson & Johnson Company Information
  15. 4.3.2 Johnson & Johnson Business Overview
  16. 4.3.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Johnson & Johnson Oral Anticoagulants Product Portfolio
  18. 4.3.5 Johnson & Johnson Recent Developments
  19. 4.4 GSK
  20. 4.4.1 GSK Company Information
  21. 4.4.2 GSK Business Overview
  22. 4.4.3 GSK Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 GSK Oral Anticoagulants Product Portfolio
  24. 4.4.5 GSK Recent Developments
  25. 4.5 Daiichi Sankyo
  26. 4.5.1 Daiichi Sankyo Company Information
  27. 4.5.2 Daiichi Sankyo Business Overview
  28. 4.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Daiichi Sankyo Oral Anticoagulants Product Portfolio
  30. 4.5.5 Daiichi Sankyo Recent Developments
  31. 4.6 Bayer
  32. 4.6.1 Bayer Company Information
  33. 4.6.2 Bayer Business Overview
  34. 4.6.3 Bayer Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Bayer Oral Anticoagulants Product Portfolio
  36. 4.6.5 Bayer Recent Developments
  37. 4.7 AstraZeneca
  38. 4.7.1 AstraZeneca Company Information
  39. 4.7.2 AstraZeneca Business Overview
  40. 4.7.3 AstraZeneca Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AstraZeneca Oral Anticoagulants Product Portfolio
  42. 4.7.5 AstraZeneca Recent Developments
  43. 4.8 Perosphere
  44. 4.8.1 Perosphere Company Information
  45. 4.8.2 Perosphere Business Overview
  46. 4.8.3 Perosphere Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Perosphere Oral Anticoagulants Product Portfolio
  48. 4.8.5 Perosphere Recent Developments
  49. 4.9 Ockham Biotech
  50. 4.9.1 Ockham Biotech Company Information
  51. 4.9.2 Ockham Biotech Business Overview
  52. 4.9.3 Ockham Biotech Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ockham Biotech Oral Anticoagulants Product Portfolio
  54. 4.9.5 Ockham Biotech Recent Developments
  55. 4.10 Marathon Pharmaceuticals
  56. 4.10.1 Marathon Pharmaceuticals Company Information
  57. 4.10.2 Marathon Pharmaceuticals Business Overview
  58. 4.10.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio
  60. 4.10.5 Marathon Pharmaceuticals Recent Developments
  61. 4.11 CSL Behring
  62. 4.11.1 CSL Behring Company Information
  63. 4.11.2 CSL Behring Business Overview
  64. 4.11.3 CSL Behring Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 CSL Behring Oral Anticoagulants Product Portfolio
  66. 4.11.5 CSL Behring Recent Developments
  67. 4.12 Cosmo Pharmaceuticals
  68. 4.12.1 Cosmo Pharmaceuticals Company Information
  69. 4.12.2 Cosmo Pharmaceuticals Business Overview
  70. 4.12.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio
  72. 4.12.5 Cosmo Pharmaceuticals Recent Developments
  73. 4.13 Cellceutix
  74. 4.13.1 Cellceutix Company Information
  75. 4.13.2 Cellceutix Business Overview
  76. 4.13.3 Cellceutix Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Cellceutix Oral Anticoagulants Product Portfolio
  78. 4.13.5 Cellceutix Recent Developments
  79. 4.14 Bristol-Myers Squibb
  80. 4.14.1 Bristol-Myers Squibb Company Information
  81. 4.14.2 Bristol-Myers Squibb Business Overview
  82. 4.14.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bristol-Myers Squibb Oral Anticoagulants Product Portfolio
  84. 4.14.5 Bristol-Myers Squibb Recent Developments
  85. 4.15 Boehringer Ingelheim
  86. 4.15.1 Boehringer Ingelheim Company Information
  87. 4.15.2 Boehringer Ingelheim Business Overview
  88. 4.15.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Boehringer Ingelheim Oral Anticoagulants Product Portfolio
  90. 4.15.5 Boehringer Ingelheim Recent Developments
  91. 4.16 Aspen
  92. 4.16.1 Aspen Company Information
  93. 4.16.2 Aspen Business Overview
  94. 4.16.3 Aspen Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Aspen Oral Anticoagulants Product Portfolio
  96. 4.16.5 Aspen Recent Developments
  97. 4.17 Armatheon
  98. 4.17.1 Armatheon Company Information
  99. 4.17.2 Armatheon Business Overview
  100. 4.17.3 Armatheon Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Armatheon Oral Anticoagulants Product Portfolio
  102. 4.17.5 Armatheon Recent Developments
5 Global Oral Anticoagulants Market Scenario by Region
  1. 5.1 Global Oral Anticoagulants Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Anticoagulants Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Anticoagulants Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Anticoagulants Sales by Region: 2027-2032
  5. 5.3 Global Oral Anticoagulants Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Anticoagulants Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Anticoagulants Revenue by Region: 2027-2032
  8. 5.4 North America Oral Anticoagulants Market Facts & Figures by Country
  9. 5.4.1 North America Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Anticoagulants Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Anticoagulants Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Anticoagulants Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Anticoagulants Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Anticoagulants Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Anticoagulants Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Anticoagulants Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Anticoagulants Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Anticoagulants Market Facts & Figures by Country
  41. 5.7.1 South America Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Anticoagulants Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Anticoagulants Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral Anticoagulants Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral Anticoagulants Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral Anticoagulants Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Anticoagulants Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Anticoagulants Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Oral Anticoagulants Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Anticoagulants Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Anticoagulants Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Anticoagulants Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Anticoagulants Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Anticoagulants Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Anticoagulants Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Oral Anticoagulants Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Anticoagulants Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Anticoagulants Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Anticoagulants Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Anticoagulants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Anticoagulants Value Chain Analysis
  2. 8.1.1 Oral Anticoagulants Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Anticoagulants Production Mode & Process
  5. 8.2 Oral Anticoagulants Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Anticoagulants Distributors
  8. 8.2.3 Oral Anticoagulants Customers
9 Global Oral Anticoagulants Analyzing Market Dynamics
  1. 9.1 Oral Anticoagulants Industry Trends
  2. 9.2 Oral Anticoagulants Industry Drivers
  3. 9.3 Oral Anticoagulants Industry Opportunities and Challenges
  4. 9.4 Oral Anticoagulants Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst